Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Indonesia
Indonesia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.7% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Indonesia, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Indonesia stood at 0.7%. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 12.5% on the previous year and down 30.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Indonesia peaked at 1.0% in 2015 and was at its lowest, 0.7%, in 2024.
That places Indonesia 51st out of 247 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.0% | — |
| 2016 | 0.9% | -10.0% |
| 2017 | 0.9% | +0.0% |
| 2018 | 0.9% | +0.0% |
| 2019 | 0.8% | -11.1% |
| 2020 | 0.9% | +12.5% |
| 2021 | 0.9% | +0.0% |
| 2022 | 0.9% | +0.0% |
| 2023 | 0.8% | -11.1% |
| 2024 | 0.7% | -12.5% |
Indonesia compared with similar countries
- Indonesia's 0.7% is above the median for upper middle income countries, which is 0.2%, 3.5× the median. (55 countries reporting)
- Indonesia's 0.7% is above the median for East Asia & Pacific, which is 0.6%, 1.2× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.9% | 0.8% | 1.0% | 5 |
| 2020s | 0.8% | 0.7% | 0.9% | 5 |
Countries ranked near Indonesia
- 51 Benin 0.7% compare
- 51 Brunei Darussalam 0.7% compare
- 51 Burkina Faso 0.7% compare
- 51 Cabo Verde 0.7% compare
- 51 Kenya 0.7% compare
- 51 Liberia 0.7% compare
- 51 Sierra Leone 0.7% compare
- 51 Brunei 0.7% compare
More development goals data for Indonesia
- Red List Index 0.8248 (2025)
- Number of refugees per 100,000 population, by country of origin 3.21 (2025)
- Manufacturing value added per capita 915.42 (2025)
- Number of transboundary breeds 53 (2025)
- Number of transboundary breeds (not extinct) 53 (2025)
- Number of transboundary breeds with unknown risk status 46 (2025)
- Number of local breeds with unknown risk status 153 (2025)
- Number of local breeds (not extinct) 171 (2025)
- Number of local breeds kept in the country 173 (2025)
- Infant deaths 67,732 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Indonesia?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Indonesia was 0.7% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Indonesia?
- The highest recorded value was 1.0% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Indonesia?
- The lowest recorded value was 0.7% in 2024.
- How does Indonesia rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Indonesia ranks 51st out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Indonesia?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Indonesia data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).